Highlights
composition with strength
Remogliflozin Etabonate (100mg), Metformin (500mg)
description
Controls high blood glucose levels, helps reduce cardiovascular risk, supports insulin utilization, aids in diabetes management
key benefits
Treatment of Type 2 diabetes mellitus
side effects
Nausea, Vomiting, Diarrhea, Abdominal pain, Loss of appetite and Hypoglycemia (low blood glucose level)
how to use
Take this medicine in the exact dose and duration as prescribed by your doctor
alcohol interaction
Unsafe
pregnancy interaction
Unsafe
lactation interaction
Unsafe
driving interaction
Safe
kidney interaction
Caution
liver interaction
Unsafe
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Drogheria Sellers Private Limited
Seller Address
Brigade IRV, 9th & 10th Floors, Nallurhalli, White Field, Bangalore, Banglore, Karnataka, India, 560066 For Support ReachOut : support+drogheria@zeptonow.com
Pharmacy License No.
MH-TZ1-581061, MH-TZ1-581062
Manufacturer or Marketer Address
8th Floor, Sarovar Complex, C.G Road, Ahmedabad 380009, Gujarat, India.
Country of Origin
India
Manufacturer or Marketer Name
Glenmark Pharmaceuticals Limited
Shelf Life
24 months
Expires on or after
December 2026
